The invention provides controlled-release formulations for oral administration containing a cGMP PDE-5 inhibitor. The formulations are useful, inter alia, in the treatment or prevention of sexual dysfunction.

 
Web www.patentalert.com

< Excipients containing low residual solvent and method for producing the same

< Carbon dioxide compatible non-aqueous crosslinked fracturing fluids and methods for their use

> Sustained release drug delivery devices with prefabricated permeable plugs

> Transdermal patch for delivering volatile liquid drugs
~ 00220